NO20013044D0 - Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater - Google Patents

Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater

Info

Publication number
NO20013044D0
NO20013044D0 NO20013044A NO20013044A NO20013044D0 NO 20013044 D0 NO20013044 D0 NO 20013044D0 NO 20013044 A NO20013044 A NO 20013044A NO 20013044 A NO20013044 A NO 20013044A NO 20013044 D0 NO20013044 D0 NO 20013044D0
Authority
NO
Norway
Prior art keywords
deazadenosine
derivatives
substituted
preparation
substituted deazadenosine
Prior art date
Application number
NO20013044A
Other languages
English (en)
Other versions
NO20013044L (no
NO319789B1 (no
Inventor
Richard SALAZAR
Original Assignee
Aventis Pharm Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharm Prod Inc filed Critical Aventis Pharm Prod Inc
Publication of NO20013044D0 publication Critical patent/NO20013044D0/no
Publication of NO20013044L publication Critical patent/NO20013044L/no
Publication of NO319789B1 publication Critical patent/NO319789B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20013044A 1998-12-21 2001-06-19 Fremgangsmate for fremstilling av NG-substituerte deaza-adenosinderivater og fremgangsmate for fremstilling av mellomprodukter. NO319789B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21
PCT/US1999/029643 WO2000037469A2 (en) 1998-12-21 1999-12-14 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (3)

Publication Number Publication Date
NO20013044D0 true NO20013044D0 (no) 2001-06-19
NO20013044L NO20013044L (no) 2001-08-20
NO319789B1 NO319789B1 (no) 2005-09-12

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013044A NO319789B1 (no) 1998-12-21 2001-06-19 Fremgangsmate for fremstilling av NG-substituerte deaza-adenosinderivater og fremgangsmate for fremstilling av mellomprodukter.

Country Status (28)

Country Link
US (1) US6184382B1 (no)
EP (1) EP1175420B1 (no)
JP (1) JP2002533343A (no)
KR (1) KR20010087425A (no)
CN (1) CN1122667C (no)
AP (1) AP1336A (no)
AT (1) ATE235493T1 (no)
AU (1) AU774155B2 (no)
BG (1) BG105624A (no)
BR (1) BR9917088A (no)
CA (1) CA2357760A1 (no)
CZ (1) CZ20012283A3 (no)
DE (1) DE69906392T2 (no)
DK (1) DK1175420T3 (no)
EA (1) EA003645B1 (no)
EE (1) EE200100333A (no)
ES (1) ES2191489T3 (no)
HK (1) HK1041607A1 (no)
HU (1) HUP0105224A3 (no)
ID (1) ID30118A (no)
IL (1) IL143843A0 (no)
NO (1) NO319789B1 (no)
NZ (1) NZ512500A (no)
PL (1) PL349154A1 (no)
PT (1) PT1175420E (no)
SK (1) SK284767B6 (no)
WO (1) WO2000037469A2 (no)
YU (1) YU51401A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713705A (pt) * 1996-12-11 2000-05-09 Rhone Poulenc Rorer Pharma Composto, e, processo para a preparação do mesmo
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
WO1992005177A1 (en) * 1990-09-25 1992-04-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AP1336A (en) 2004-11-30
SK9072001A3 (en) 2001-12-03
IL143843A0 (en) 2002-04-21
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
NO20013044L (no) 2001-08-20
DE69906392D1 (de) 2003-04-30
HUP0105224A3 (en) 2003-01-28
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
PT1175420E (pt) 2003-08-29
EE200100333A (et) 2002-08-15
AP2001002200A0 (en) 2001-09-30
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
EA200100697A1 (ru) 2001-12-24
NO319789B1 (no) 2005-09-12
HK1041607A1 (zh) 2002-07-12
CZ20012283A3 (cs) 2001-10-17
EP1175420A2 (en) 2002-01-30
ES2191489T3 (es) 2003-09-01
BG105624A (en) 2002-01-31
WO2000037469B1 (en) 2000-11-02
PL349154A1 (en) 2002-07-01
CN1122667C (zh) 2003-10-01
ID30118A (id) 2001-11-08
NZ512500A (en) 2003-01-31
DE69906392T2 (de) 2004-02-05
EA003645B1 (ru) 2003-08-28
CN1333773A (zh) 2002-01-30
BR9917088A (pt) 2006-01-31
HUP0105224A2 (en) 2002-06-29
AU2181400A (en) 2000-07-12
US6184382B1 (en) 2001-02-06
KR20010087425A (ko) 2001-09-15
WO2000037469A3 (en) 2000-09-14
YU51401A (sh) 2003-12-31
JP2002533343A (ja) 2002-10-08
EP1175420B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
NO20011936D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20024060L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20000933D0 (no) Fremgangsmåte for fremstilling av polymer
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO991679L (no) Fremgangsmaate for fremstilling av fenoksyfenylsulfonylhalider
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO20005818L (no) Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO20006686D0 (no) Fremgangsmåte for fremstilling av ammoniakk
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater